Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial
Cécile Jovelet(Centre National de la Recherche Scientifique), Ludovic Lacroix(Centre National de la Recherche Scientifique), Amélie Boichard(Centre National de la Recherche Scientifique), Thierry de Baère(Institut Gustave Roussy), Jean‐Charles Soria(Inserm), Maud Ngo‐Camus(Institut Gustave Roussy), Marie‐Cécile Le Deley(Institut Gustave Roussy), Jean‐Yves Scoazec(Université Paris-Saclay), Nelly Motté(Centre National de la Recherche Scientifique), Alexander M.M. Eggermont(University Medical Center Utrecht), Gilles Vassal(Université Paris-Saclay), Philippe Vielh(Hôpital américain de paris), Marion Pedrero(Inserm), Silvia Rosellini(Institut Gustave Roussy), Noémie Pata-Merci(Centre National de la Recherche Scientifique), Antoine Hollebecque(Institut Gustave Roussy), Marc Deloger(Centre National de la Recherche Scientifique), Christophe Massard(Institut Gustave Roussy), Nathalie Droin(Centre National de la Recherche Scientifique), Céline Lefèbvre, Alfredo Romero(Centre National de la Recherche Scientifique), Charles Ferté(CentraleSupélec), Fabrice André(Inserm), Ecaterina Ileana(Centre National de la Recherche Scientifique), Sophie Postel‐Vinay(Université Paris-Sud)
Cited by 124
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|2.3k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k